Completed PHASE4 INTERVENTIONAL 2-arm NCT05956899

Palonosetron vs Ondansetron In PONV Prophylaxis Among Idiopathic Scoliosis Patients (PONV)

A Comparison Between Palonosetron And Ondansetron As Prophylaxis Against Postoperative Nausea and Vomiting In Idiopathic Scoliosis Surgery: A Randomised Trial

Sponsor: University of Malaya

Conditions Idiopathic Scoliosis Postoperative Nausea and Vomiting

Interventions Ondansetron Palonosetron

Updated 5 times since 2023 Last updated: Dec 8, 2024 Started: Jun 1, 2023 Primary completion: Mar 20, 2024 Completion: May 2, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Idiopathic Scoliosis and Postoperative Nausea and Vomiting and is currently completed. University of Malaya leads this study, which shows 5 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Jan 2025 — Present [monthly]

Completed PHASE4

Status: Recruiting → Completed
Sep 2024 — Jan 2025 [monthly]

Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE4
Mar 2024 — Jul 2024 [monthly]

Recruiting PHASE4
Aug 2023 — Mar 2024 [monthly]

Recruiting PHASE4

First recorded

Jun 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Malaya

Data source: University of Malaya

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pantai Valley, Malaysia